Top compounds associated with response to SPTY2D1-AS1


Feature Type Standardized
Nominal ANOVA
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.099 0.01
mRNA Bortezomib gCSI pan-cancer AAC -0.15 0.01
mRNA C6-ceramide CTRPv2 pan-cancer AAC 0.095 0.01
mRNA Nilotinib CCLE pan-cancer AAC -0.12 0.01
mRNA NVP-BSK805 CTRPv2 pan-cancer AAC 0.083 0.02
mRNA BRD9876:MK-1775 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.3 0.02
mRNA GDC-0941 CTRPv2 pan-cancer AAC 0.086 0.02
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.08 0.02
mRNA BRD-A94377914 CTRPv2 pan-cancer AAC 0.1 0.02
mRNA piperlongumine:MST-312 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.083 0.02
Download CSV